Basit öğe kaydını göster

dc.contributor.authorGerceker, A. A.
dc.contributor.authorBozkurt-Guzel, C.
dc.date.accessioned2021-03-05T20:01:08Z
dc.date.available2021-03-05T20:01:08Z
dc.date.issued2012
dc.identifier.citationBozkurt-Guzel C., Gerceker A. A. , "In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin against Pseudomonas aeruginosa", INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, cilt.30, ss.34-38, 2012
dc.identifier.issn0255-0857
dc.identifier.othervv_1032021
dc.identifier.otherav_d20ca0d0-75f8-4662-8d4a-82932069e8a3
dc.identifier.urihttp://hdl.handle.net/20.500.12627/138797
dc.identifier.urihttps://doi.org/10.4103/0255-0857.93020
dc.description.abstractPurpose: In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin were investigated by studying time-kill kinetics and post-antibiotic effect (PAE) against strains of Pseudomonas aeruginosa isolated from patients with cystic fibrosis. Method: Synergy was investigated at 0.5x, 1x and 5x MIC of antibiotics using time-kill curve method. PAEs were determined by the standard viable counting method where bacteria in the logarithmic phase of growth were exposed for 1 h to the antibiotics at 1x or 20x MIC, alone and in combinations. Synergy and additive effects were detected at 1xMIC, at 24 h. Results: Some of the strains produced an earlier synergistic effect at 12 h. No antagonism was observed. Colistin methanesulfonate and amikacin produced PAEs 1.16 +/- 0.10 to 2.25 +/- 0.16 h and 0.96 +/- 0.15 to 2.69+/-0.32 h, respectively. When the antibiotics were used in combination the PAEs were prolonged to a value of 3.88+/-0.25 h. Consequently, the Conclusions: Findings of this study may play useful role in selecting the appropriate combinations when a single agent is inadequate, and may have important information for optimizing the dose intervals.
dc.language.isoeng
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTemel Bilimler
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri
dc.titleIn vitro pharmacodynamic properties of colistin methanesulfonate and amikacin against Pseudomonas aeruginosa
dc.typeMakale
dc.relation.journalINDIAN JOURNAL OF MEDICAL MICROBIOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume30
dc.identifier.issue1
dc.identifier.startpage34
dc.identifier.endpage38
dc.contributor.firstauthorID86658


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster